Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes
Abstract Stem cell derived insulin producing cells or islets have shown promise in reversing Type 1 Diabetes (T1D), yet successful transplantation currently necessitates long‐term modulation with immunosuppressant drugs. An alternative approach to avoiding this immune response is to utilize an islet...
Main Authors: | Debkalpa Goswami, Daniel A. Domingo‐Lopez, Niamh A. Ward, Jeffrey R. Millman, Garry P. Duffy, Eimear B. Dolan, Ellen T. Roche |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202100820 |
Similar Items
-
Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes
by: Goswami, Debkalpa, et al.
Published: (2022) -
Human islet isolation: status and future considerations*
by: R. Bottino, et al.
Published: (2019-04-01) -
An in vitro Perfused Macroencapsulation Device to Study Hemocompatibility and Survival of Islet-Like Cell Clusters
by: Stephanie A. Fernandez, et al.
Published: (2021-05-01) -
VEGF-Modified PVA/Silicone Nanofibers Enhance Islet Function Transplanted in Subcutaneous Site Followed by Device-Less Procedure
by: Yang B, et al.
Published: (2020-01-01) -
Cardiac implantable therapeutic medical devices: A narrative review
by: Christine Pui Sum Ho, et al.
Published: (2021-01-01)